Saltsjö-Boo, Sweden

Caroline Ekblad

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Saltsjo-Boo, SE (2015 - 2019)
  • Saltsjö-Boo, SE (2018 - 2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Caroline Ekblad: Innovator in Polypeptide Research

Introduction

Caroline Ekblad, based in Saltsjö-Boo, Sweden, is an accomplished inventor known for her contributions to the field of polypeptides. With a total of eight patents to her name, she has established herself as an influential figure in protein engineering, particularly through her latest research.

Latest Patents

Among her recent patents, one significant disclosure relates to polypeptides based on a scaffold. This patent outlines a population of polypeptide variants, each incorporating the essential scaffold amino acid sequence XAELDXXGVG AXXIKXIXXA XXVEXVQXXK QXILAX. The methods for selecting and identifying these polypeptides are also detailed, highlighting their potential uses. Another notable patent pertains to engineered polypeptides designed to bind with the neonatal Fc receptor (FcRn). This invention, identified by the sequence EXXXAXXEIRWLPNL XXXQRXAFIXXLXX, is proposed for its utility in modifying pharmacokinetic and pharmacodynamic properties, serving as a promising therapeutic agent.

Career Highlights

Caroline currently works at Affibody AB, a company that specializes in developing innovative protein-based therapeutics. Her role has enabled her to explore the intricacies of polypeptide engineering, leading to numerous applications in the biomedical field. Her dedication to research and innovation is evident through the successful patents she has registered, which are contributing to advancements in treatment methods and drug efficacy.

Collaborations

Throughout her career, Caroline has collaborated with esteemed colleagues such as Lars B. Abrahmsen and Elin Gunneriusson. These partnerships have facilitated the exchange of ideas and fostered a creative environment for innovation in protein research. Together, they have worked on various projects that underline their commitment to advancing health sciences.

Conclusion

Caroline Ekblad represents the forefront of innovation in polypeptide research. With her numerous patents and collaborations, she is making significant strides in the scientific community. Her work at Affibody AB exemplifies her dedication to improving therapeutic options through groundbreaking research in engineered proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…